Related Experiment Video
Updated: May 11, 2026

Standardized Technique of Aortic Valve Re-implantation for Valve-sparing Aortic Root Replacement
Published on: December 11, 2017
Can statins improve outcomes after isolated cardiac valve surgery? A systematic literature review
Jacob Chacko1, Leanne Harling, Hutan Ashrafian
1Department of Surgery and Cancer, Imperial College London, London, United Kingdom.
Insights
Statins (3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors) show no clear benefit in isolated valve surgery outcomes. More research is needed to determine if statins alone improve patient results after valve replacement.
Area of Science:
- Cardiovascular Surgery
- Pharmacology
- Clinical Outcomes
Background:
- Statins are known to improve outcomes in coronary artery surgery.
- The role of statins in isolated valve surgery (IVS) is not well-established.
- Pleiotropic effects of statins may benefit patients undergoing IVS.
Purpose of the Study:
- To investigate the role of statin therapy in bioprosthetic valve replacement.
- To determine if statins confer a postoperative benefit in isolated valve surgery.
Main Methods:
- Systematic review of the literature.
- Inclusion of nine observational studies (7 retrospective, 2 prospective).
- Analysis of data from 18,154 patients.
Main Results:
- Nine studies involving 18,154 patients were analyzed.
- The studies focused on statin therapy in bioprosthetic valve replacement.
- Current evidence is insufficient to support routine statin use in IVS.
Conclusions:
- Insufficient evidence exists to recommend routine statin therapy for isolated valve surgery.
- Statin therapy may be considered if hypercholesterolemia or coronary artery disease is present.
- Prospective studies are required to define optimal statin therapy for postoperative benefit.
Background:
HMG CoA (3-hydroxy-3-methylglutaryl coenzyme A) reductase inhibitors, or statins, have been associated with an improvement in outcomes after coronary artery surgery for some time; however, their role in isolated valve surgery (IVS) remains undetermined.
Hypothesis:
The pleiotropic effects of statins may produce similar beneficial effects on outcomes after IVS.
Methods:
A systematic review of the literature was performed investigating the role of statins in bioprosthetic valve replacement.
Results:
Nine observational studies (7 retrospective, 2 prospective) incorporating a total of 18 154 patients were found investigating the role of statin therapy in bioprosthetic valve replacement.
Conclusions:
There is presently insufficient evidence to recommend routine statin therapy in IVS, unless concomitant hypercholesterolemia or coronary artery disease is present. A prospective study clearly defining the dose, type, and duration of therapy is now required to finally clarify whether statins alone confer a postoperative benefit in these patients.
Related Concept Videos
Mitral Stenosis III: Medical Management
Atherosclerosis III: Management
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Mitral Stenosis IV: Nursing Management
Coronary Artery Disease V: Interprofessional Care
Cardiomyopathy VII: Pre and Post Operative Nursing Management
